UniSuper Management Pty Ltd Purchases 157,370 Shares of Colgate-Palmolive Company $CL

UniSuper Management Pty Ltd lifted its position in shares of Colgate-Palmolive Company (NYSE:CL) by 18.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,008,105 shares of the company’s stock after purchasing an additional 157,370 shares during the period. UniSuper Management Pty Ltd owned about 0.13% of Colgate-Palmolive worth $79,660,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Canopy Partners LLC bought a new stake in shares of Colgate-Palmolive during the fourth quarter worth about $201,000. Coastwise Capital Group LLC grew its holdings in shares of Colgate-Palmolive by 13.2% during the fourth quarter. Coastwise Capital Group LLC now owns 3,565 shares of the company’s stock worth $282,000 after purchasing an additional 416 shares during the last quarter. SmartHarvest Portfolios LLC bought a new stake in shares of Colgate-Palmolive during the fourth quarter worth about $315,000. Vestor Capital LLC grew its holdings in shares of Colgate-Palmolive by 1,371.6% during the fourth quarter. Vestor Capital LLC now owns 31,786 shares of the company’s stock worth $2,512,000 after purchasing an additional 29,626 shares during the last quarter. Finally, Walter & Keenan Wealth Management LLC IN ADV bought a new stake in shares of Colgate-Palmolive during the fourth quarter worth about $213,000. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $89.48 on Friday. The stock’s 50 day moving average is $86.77 and its 200 day moving average is $86.23. The company has a debt-to-equity ratio of 16.33, a current ratio of 1.02 and a quick ratio of 0.67. The firm has a market cap of $71.60 billion, a P/E ratio of 34.82, a P/E/G ratio of 4.74 and a beta of 0.33. Colgate-Palmolive Company has a one year low of $74.54 and a one year high of $99.33.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, May 1st. The company reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.94 by $0.03. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.The firm had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.22 billion. During the same period in the previous year, the firm earned $0.91 earnings per share. The company’s revenue was up 8.4% compared to the same quarter last year. As a group, research analysts expect that Colgate-Palmolive Company will post 3.81 EPS for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Monday, July 20th will be paid a $0.53 dividend. The ex-dividend date of this dividend is Monday, July 20th. This represents a $2.12 annualized dividend and a yield of 2.4%. Colgate-Palmolive’s payout ratio is 82.49%.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the company. Sanford C. Bernstein assumed coverage on Colgate-Palmolive in a research note on Thursday. They issued a “market perform” rating and a $96.00 price objective on the stock. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $99.00 price objective on shares of Colgate-Palmolive in a research note on Monday, May 4th. Morgan Stanley reaffirmed an “overweight” rating on shares of Colgate-Palmolive in a research note on Monday, May 4th. JPMorgan Chase & Co. lifted their price objective on Colgate-Palmolive from $95.00 to $96.00 and gave the stock an “overweight” rating in a research note on Monday, May 4th. Finally, UBS Group lifted their price objective on Colgate-Palmolive from $98.00 to $100.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. Twelve analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat.com, Colgate-Palmolive currently has an average rating of “Moderate Buy” and a consensus target price of $95.88.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.